Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase: A pilot study

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 47, Issue 2, 2002, Pages 137-143

  Ferrari, Bruno ^a   Barusi, Lorenzo ^a   Coppola, Francesco ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Embryo transfer; Fertilization, in vitro; Follicle stimulating hormone; Gonadotropin releasing hormone; Gonadotropins, chorionic

Indexed keywords

ANDROSTENEDIONE; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INFERTILITY THERAPY; MENSTRUAL CYCLE; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; TREATMENT OUTCOME;

CHORIONIC GONADOTROPIN; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; PILOT PROJECTS; PROSPECTIVE STUDIES; TRIPTORELIN;

EID: 0036194559     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Response to repetitive cycles of ovulation induction in the same women
2. Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age
3. Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test
4. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization
5. Gonadotrophins, steroid and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles
6. A rational approach to the management of low responders in in-vitro fertilization
7. Gonadotropin-binding sites in the rhesus monkey ovary: A role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle
8. Use of the flare-up protocol with high dose human follicle-stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders
9. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization and gamete intrafallopian transfer cycles
10. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular midluteal, or late luteal phase in normal cycling women
11. Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels
12. FSH induction of functional LH receptors in granulosa cells cultured in chemically defined medium
13. Follicular development and early luteal function of conception and nonconceptional cycles after human in vitro fertilization: Endocrine correlates
14. Profertility uses of LhRh agonist analogues
15. Hypersecretion of luteinizing hormone, infertility and miscarriage
16. The production of progesterone, androgens and estrogens by granulosa cells, thecal tissue and stromal tissue from human ovaries in vitro
17. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency
18. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency
19. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome
20. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone
21. A double-blind, randomised, dose-finding study to assess the efficacy of the GnRH antagonist Ganirelix (Org 37462) to prevent premature LH surges in women undergoing controlled ovarian hyperstimulation with recombinant FSH (Puregon)
22. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations
23. The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels
24. Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone-agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels
25. Induction of luteolysis by luteinizing hormone releasing factor (LRF) agonist: Sensitivity, reproducibility and reversibility
26. Steroids in the follicular fluid and the corpus luteum of the mare: A two cell type theory of ovarian steroid synthesis
27. Studies of the mechanism(s) of mammalian ovulation